Christopher D. richardson
Professor and Canada Research Chair, Tier1
Department of Microbiology and Immunology
Dalhousie University
Canada
Biography
Dr. CHRISTOPHER D. RICHARDSON is affiliated to Department of Microbiology and Immunology, Dalhousie University. Dr. CHRISTOPHER D. RICHARDSON is currently providing services as Professor and Canada Research Chair, Tier1. Dr. CHRISTOPHER D. RICHARDSON has authored I145and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. CHRISTOPHER D. RICHARDSON contributions have acclaimed recognition from honourable subject experts around the world. Dr. CHRISTOPHER D. RICHARDSON is actively associated with different societies and academies. Dr. CHRISTOPHER D. RICHARDSON academic career is decorated with several reputed awards and funding. Dr. CHRISTOPHER D. RICHARDSON research interests include My research involves the molecular biology of measles, canine distemper, hepatitis C, and hepatitis B viruses. We are particularly interested in virus-host cell receptor interactions. Many of these receptors have been found to be highly up-regulated on cancer cells and can be targeted for therapy by recombinant oncolytic viruses..
Research Interest
My research involves the molecular biology of measles, canine distemper, hepatitis C, and hepatitis B viruses. We are particularly interested in virus-host cell receptor interactions. Many of these receptors have been found to be highly up-regulated on cancer cells and can be targeted for therapy by recombinant oncolytic viruses.
Publications
-
Noyce R.S. and Richardson C.D. (2012) Nectin 4 is the Epithelial Cell Receptor for Measles Virus. Trends Microbiol. 20(9):429-39
-
Dörig, R., Marcil, A., Chopra, A., and Richardson, C.D. (1993). The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75, 295-305.
-
Hsu, E.C., His, B., Hirota-Tsuchihara, M., Ruland, J., Iorio, C., Sarangi, F., Diao, J., Migliaccio, G., Tyrrell, D.L., Kneteman, N., and Richardson, C.D. (2003). Modified apoptotic molecule (BID) reduces hepatitis C virus infection in mice with chimeric human livers. Nature Biotechnology 21: 519-525
